The detection of myocardial ischemia in end-stage renal disease

Current Opinion in Investigational Drugs

Volumn 8, Issue 3, 2007, Pages 232-236

  Sharma, Rajan ^a   Pellerin, Denis ^a   Brecker, Stephen J D ^a  

^a EALING HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Biomarker; Cardiac risk; Dobutamine stress echocardiography; End stage renal disease; Ischemiamodified albumin; Myocardial ischemia

Indexed keywords

ADENOSINE; ALBUMIN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CONTRAST MEDIUM; CREATINE KINASE; DIPYRIDAMOLE; DITHIOTHREITOL; DOBUTAMINE; FREE RADICAL; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOISOTOPE; REDUCING AGENT; TECHNETIUM 99M; TETROFOSMIN; THALLIUM 201; TRACER; TROPONIN I;

COLOR ULTRASOUND FLOWMETRY; DIAGNOSTIC IMAGING; DRUG UPTAKE; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; KIDNEY FAILURE; PREDICTOR VARIABLE; REST; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SILENT MYOCARDIAL ISCHEMIA; STRATIFICATION; STRESS ECHOCARDIOGRAPHY;

BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY, STRESS; HUMANS; KIDNEY FAILURE, CHRONIC; MYOCARDIAL ISCHEMIA; RADIONUCLIDE IMAGING;

EID: 33947308896     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS: Acute myocardial infarction and renal dysfunction: A high-risk combination. Ann Intern Med (2002) 137(7):563-570. • A retrospective cohort study of 3106 patients with acute MI and renal insufficiency is described. Patients with renal failure were at increased risk for death after acute MI and received less aggressive treatment than patients with normal renal function.
2. Gibson CM, Pinto DS, Murphy SA, Morrow DA, Hobbach HP, Wiviott SD, Giugliano RP, Cannon CP, Antman EM, Braunwald E: Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol (2003) 42(9):1535- 1543. • Data drawn from the Thrombolysis In MI (TIMI)-10, TIMI-14 and Intravenous nPA for the Treatment of Infarcting Myocardium Early (InTIME-II) clinical trials are presented here. In the setting of ST-elevation MI, elevated impaired creatinine clearance on presentation was associated with increased mortality, independent of other conventional risk factors.
3. Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, Granger CB, Ohman EM, Holmes DR Jr: Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation (2002) 106(8):974-980.
4. Braun WE, Marwick TH: Coronary artery disease in renal transplant recipients. Cleve Clin J Med (1994) 61(5):370-385.
5. Sharma R, Pellerin D, Gaze DC, Gregson H, Streather CP, Collinson PO, Brecker SJ: Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant (2005) 20(10):2207-2214. • A prospective observational study of 125 patients with ESRD is described. All patients underwent coronary angiography, DSE and exercise ECG testing. In a multivariate model including traditional risk factors and cTnT, DSE and an abnormal baseline ECG were the only independent predictors of significant CAD. Cardiac symptoms and exercise ECG did not predict coronary disease in these patients.
6. Apple FS, Murakami MM, Pearce LA, Herzog CA: Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, highsensitivity C-reactive protein, and cardiac troponin T and I in endstage renal disease for all-cause death. Clin Chem (2004) 50(12):2279-2285. •• This study determined the prognostic value of multiple biomarkers for allcause death over two years in 399 ESRD patients. Increased plasma highsensitivity C-reactive protein, cTnT and cTnI above the cutoffs for a reference (eg, normal) population were all independently predictive of subsequent death in ESRD patients. Tertile analysis for NT-proBNP also demonstrated prognostic value.
7. Heyndrickx C, Baig H, Nellins P, Leusen I, Fishbein MC, Vatner SF: Depression of regional blood flow and wall thickening after brief coronary occlusion. Am J Physiol (1978) 234(6):H653-H659.
8. Rostand SG, Kirk KA, Rutsky EA: The epidemiology of coronary artery disease in patients on maintenance hemodialysis: Implications for management. Contrib Nephrol (1986) 52:34-41.
9. Holley JL, Fenton RA, Arthur RS: Thallium stress testing does not predict cardiovascular risk in diabetic patients with end-stage renal disease undergoing cadaveric renal transplantation. Am J Med (1991) 90(5):563-570.
10. Patel AD, Abo-Auda WS, Davis JM, Zoghbi GJ, Deierhoi MH, Heo J, Iskandrian AE: Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation. Am J Cardiol (2003) 92(2):146-151. • This study examined the prognostic significance of MPI in 600 patients undergoing renal transplantation. Pre-operative stress perfusion imaging performed on high-risk patients (most of whom had diabetes) showed that significantly less cardiac events occurred in those with normal images than those with abnormal images.
11. Sharma R, Pellerin D, Gaze DC, Shah JS, Streather CP, Collinson PO, Brecker SJ: Dobutamine stress echocardiography and cardiac troponin T for the detection of significant coronary artery disease and predicting outcome in renal transplant candidates. Eur J Echocardiogr (2005) 6(5):327-335.
12. Picano E, Lattanzi F, Orlandini A, Marini C, L'Abbate A: Stress echocardiography and the human factor: the importance of being an expert. J Am Coll Cardiol (1991) 17(3):666-669.
13. Harrison AP, Nielsen AH, Eidemak I, Molsted S, Bartels EM: The uremic environment and muscle dysfunction in man and rat. Nephron Physiol (2006) 103(1):33-42.
14. Dierkes J, Domrose U, Westphal S, Ambrosch A, Bosselmann HP, Neumann KH, Luley C: Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation (2000) 102(16):1964-1969. • This report describes 102 hemodialysis patients that were prospectively studied over a two-year period. Total homocysteine and cTnT were important predictors of mortality, whereas other laboratory variables and baseline disease status had less prognostic value.
15. Voisine P, Li J, Bianchi C, Khan TA, Ruel M, Xu SH, Feng J, Rosinberg A, Malik T, Nakai Y, Sellke FW: Effects of L-arginine on fibroblast growth factor 2-induced angiogenesis in a model of endothelial dysfunction. Circulation (2005) 112(Suppl 9):I202-I207.
16. Sharma R, Gaze DC, Pellerin D, Metha R, Gregson H, Streather CP, Collinson PO, Brecker SJ: Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T. Heart (2006) 92(6):804-809. • A prospective observational study of 126 renal transplant candidates. All patients underwent coronary angiography and ESRD patients with elevated cTnT levels were shown to have increased mortality. Elevated levels were strongly associated with diabetes, LV dilatation, impaired LV systolic and diastolic function, but not severe CAD.
17. Collinson PO, Hadcocks L, Foo Y, Rosalki SB, Stubbs PJ, Morgan SH, O'Donnell J: Cardiac troponins in patients with renal dysfunction. Ann Clin Biochem (1998) 35(Pt 3):380-386.
18. Sharma R, Gaze D, Pellerin D, Gregson H, Collinson P, Streather CP, Mehta RH, Brecker SJ: Elevated plasma N-terminal pro-B-type natriuretic peptide levels predict mortality and cardiac disease in end stage renal disease. Heart (2006): 92(10):1518-1519.
19. Goto T, Takase H, Toriyama T, Sugiura T, Kurita Y, Tsuru N, Masuda H, Hayashi K, Ueda R, Dohi Y: Increased circulating levels of natriuretic peptides predict future cardiac event in patients with chronic hemodialysis. Nephron (2002) 92(3):610-615.
20. Bar-Or D, Winkler JV, Vanbenthuysen K, Harris L, Lau E, Hetzel FW: Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: A preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J (2001) 141(6):985-991.
21. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC: Role of ischemia modified albumin, a new biochemical marker of myocardial ischemia, in the early diagnosis of acute coronary syndromes. Emerg Med J (2004) 21(1):29-34.
22. Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, Collinson PO, Brecker SJ: Ischemia-modified albumin predicts mortality in ESRD. Am J Kidney Dis (2006) 47(3):493-502. • A prospective observational study of 118 renal transplant candidates that identified IMA as a predictor of mortality in ESRD. Patients with elevated levels had larger LV size, decreased systolic function and greater estimated LV filling pressures.
23. Roy D, Quiles J, Aldama G, Sinha M, Avanzas P, Arroyo-Espliguero R, Gaze D, Collinson P, Carlos Kaski J: Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol (2004) 97(2):297-301. • This prospective study investigated 131 patients presenting to a hospital emergency department with symptoms suggestive of ACS, but with normal or non-diagnostic ECGs. After multivariate analysis, IMA levels > 85 U/ml, age, and prior MI were found to be independent predictors of ACS.